Journal list menu
Export Citations
Download PDFs
ISSUE INFORMATION
REVIEWS
Citrus fruit intake and incidence of renal cell carcinoma: A meta-analysis of observational studies
- Pages: 143-151
- First Published: 19 January 2023
The therapeutic effects of berberine for gastrointestinal cancers
- Pages: 152-167
- First Published: 13 March 2023

Multiple effects of berberine (BBR) as a gastrointestinal (GI) cancer therapeutic agent. BBR acts as a potential anti-GI cancer agent by inducing apoptosis, autophagy, and cell-cycle arrest, as well as metastasis and angiogenesis inhibition. It plays an important role in suppressing GI cancer cells.
A proposed framework for the implementation of head and neck cancer treatment at a new cancer center from a radiation oncology perspective
- Pages: 168-179
- First Published: 26 April 2023
Efficacy and adverse events of immune checkpoint inhibitors in esophageal cancer patients: Challenges and perspectives for immunotherapy
- Pages: 180-187
- First Published: 12 May 2023
Combinatorial approach of immuno-proton therapy in cancer: Rationale and potential impact
- Pages: 188-197
- First Published: 16 May 2023
Factors beyond diagnosis and treatment that are associated with return to work in Australian cancer survivors—A systematic review
- Pages: 198-209
- First Published: 25 June 2023
ORIGINAL ARTICLES
Construction and validation of a novel tumor necrosis factor-related apoptosis-inducing ligand mutant MuR5S4-TR
- Pages: 210-219
- First Published: 19 January 2023

We constructed a novel TRAIL mutant with Cell penetrating peptides (CPP) like and Second mitochondria-derived activator of caspases (Smac) like structure-MuR5S4-TR. The MuR5S4-TR showed significant stronger antitumor effects than TRAIL in many tumor cell lines, in NCI-H460 lung cancer cell both in vitro and in vivo, for instance.
Risk factors for taxane-induced peripheral neuropathy in patients with breast cancer
- Pages: 220-227
- First Published: 19 January 2023

This study assessed the clinical risk factors for peripheral neuropathy caused by the progressively more widely used but less explored taxane drugs (AP and docetaxel) in breast cancer treatment through a prospective observational design study that extensively explored controversial and potential predictors. The results of univariate and multivariate analyses showed that cumulative dose, BMI, BSA, and hypocalcemia all increased the risk of TIPN.
Combination of hyperthermia and intravesical chemotherapy for the treatment of pT1 stage bladder cancer: A retrospectively clinical study
- Pages: 228-233
- First Published: 19 January 2023
When teams disagree: Investigating the incidence and causes of dissent occurring in cancer multidisciplinary team meetings
- Pages: 234-239
- First Published: 20 January 2023
Toxicity profile of patients treated with proton and carbon-ion therapy for primary nasopharyngeal carcinoma: A systematic review and meta-analysis
- Pages: 240-250
- First Published: 22 January 2023
Functional results and feasibility of a teleprehabilitation program in patients who are candidates for elective colorectal cancer surgery during the COVID-19 pandemic
- Pages: 251-258
- First Published: 25 January 2023

Due to the pandemic, telerehabilitation services using technology to provide care to people, minimizing the barriers of distance, time, and cost were worldwide implemented. This study shows that candidates for elective colorectal cancer surgery had good functional results with telerehabilitation prior to surgery during the COVID-19 pandemic.
Measurement that matters: A systematic review and modified Delphi of multidisciplinary colorectal cancer quality indicators
- Pages: 259-274
- First Published: 01 February 2023

This study aimed to identify a priority set of quality indicators for measuring multidisciplinary colorectal cancer care in Australia. Utilising a systematic review and 2-step modified Delphi methodology, a final 26 indicators were identified across the colorectal cancer patient pathway from diagnosis to follow-up or palliative/supportive care.
Prognostic value of diffuse reduction of spleen density on postoperative survival of pancreatic ductal adenocarcinoma: A retrospective study
- Pages: 275-284
- First Published: 07 February 2023

We found that the diffuse reduction of spleen density (DROSD) is an independent risk factor for the overall survival of pancreatic ductal adenocarcinoma (PDAC). In addition, we developed a nomogram combined with imaging features, clinicopathological factors, and systemic inflammatory response to provide a personalized risk assessment for patients with PDAC.
Impact of multidisciplinary team meetings on the management of patients with breast cancer in a large private healthcare facility
- Pages: 285-291
- First Published: 15 February 2023

For optimal breast cancer care, multidisciplinary meetings are required to discuss complex cases and reach consensus decisions across multiple management categories. This study evaluated both decision-making and concordance between proposed decisions and clinical implementation for breast cancer patients at a large private hospital, noting a high uptake of recommendations.
Clinical features of gestational choriocarcinoma: A retrospective bicentric study
- Pages: 292-298
- First Published: 23 February 2023
Population attributable fractions of modifiable cancer risk factors in Korea: A systematic review
- Pages: 299-314
- First Published: 10 March 2023

This study reviewed 16 studies that reported the PAFs of risk factors for cancer, including smoking, alcohol consumption, obesity, and various cancer sites. PAF estimates for smoking and respiratory cancer were consistently high in men. PAF estimates were higher in men than in women for smoking and alcohol consumption but higher in women for obesity.
CASE REPORTS
Hemophagocytic lymphohistiocytosis (HLH) and cytokine release syndrome (CRS) in a patient with oncogene-addicted metastatic non-small cell lung cancer (NSCLC) following combination chemotherapy-immunotherapy
- Pages: 315-318
- First Published: 23 December 2022

Hematophagocytosis (HLH) and cytokine release syndrome (CRS) following administration of combination carboplatin/paclitaxel/atezolizumab/bevacizumab in a patient with oncogene-addicted metastatic non-small cell lung cancer – a rare, potentially life-threatening, irAE for oncologists to be aware of which necessitates early multidisciplinary consultation and engagement.
Selective internal radiation therapy with yttrium-90 resin microspheres followed by anatomical hepatectomy: A potential curative strategy in advanced hepatocellular carcinoma
- Pages: 319-322
- First Published: 19 January 2023